Assessment of reinforcement enhancing effects of toluene vapor and nitrous oxide in intracranial self-stimulation

Psychopharmacology

Volumn 231, Issue 7, 2014, Pages 1339-1350

  Tracy, Matthew E ^a   Slavova Hernandez, Galina G ^a   Shelton, Keith L ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Cocaine; Diazepam; ICSS; Inhalant; Intracranial self stimulation; Mice; Nitrous oxide; Progressive ratio; Rate frequency; Toluene

Indexed keywords

COCAINE; DIAZEPAM; NITROUS OXIDE; TOLUENE; GAS; STREET DRUG;

ADULT; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DEPENDENCE; DRUG DOSE COMPARISON; FOREBRAIN; INTRACRANIAL SELF STIMULATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REINFORCEMENT; REWARD; SELF ADMINISTRATION TEST; SELF STIMULATION; TASK PERFORMANCE; ADMINISTRATION AND DOSAGE; ANIMAL; C57BL MOUSE; DRUG EFFECTS; GAS; INHALATIONAL DRUG ADMINISTRATION; INSTRUMENTAL CONDITIONING; MEDIAL FOREBRAIN BUNDLE; PHARMACOLOGY; PHYSIOLOGY; VOLATILIZATION;

ADMINISTRATION, INHALATION; ANIMALS; COCAINE; CONDITIONING, OPERANT; DIAZEPAM; DOSE-RESPONSE RELATIONSHIP, DRUG; GASES; MALE; MEDIAL FOREBRAIN BUNDLE; MICE; MICE, INBRED C57BL; NITROUS OXIDE; REINFORCEMENT (PSYCHOLOGY); REINFORCEMENT SCHEDULE; REWARD; SELF STIMULATION; STREET DRUGS; TOLUENE; VOLATILIZATION;

EID: 84896489032     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-013-3327-y     Document Type: Article

References (56)

1. Altarifi AA, Negus SS (2011) Some determinants of morphine effects on intracranial self-stimulation in rats: dose, pretreatment time, repeated treatment, and rate dependence. Behav Pharmacol 22:663-673. doi: 10.1097/FBP.0b013e32834aff54
2. Balster RL, Cruz SL, Howard MO et al (2009) Classification of abused inhalants. Addiction 104:878-882. doi: 10.1111/j.1360-0443.2008.02494.x
3. Bauer CT, Banks ML, Blough BE, Negus SS (2013) Use of intracranial self-stimulation to evaluate abuse-related and abuse-limiting effects of monoamine releasers in rats. Br J Pharmacol 168:850-862. doi: 10.1111/j.1476-5381.2012.02214.x
4. Bespalov A, Sukhotina I, Medvedev I et al (2003) Facilitation of electrical brain self-stimulation behavior by abused solvents. Pharmacol Biochem Behav 75:199-208. doi: 10.1016/S0091-3057(03)00071-6
5. Blednov YA, Borghese CM, McCracken ML et al (2011) Loss of ethanol conditioned taste aversion and motor stimulation in knockin mice with ethanol-insensitive α2-containing GABA(A) receptors. J Pharmacol Exp Ther 336:145-154. doi: 10.1124/jpet.110.171645
6. Blokhina EA, Dravolina OA, Bespalov AY et al (2004) Intravenous self-administration of abused solvents and anesthetics in mice. Eur J Pharmacol 485:211-218. doi: 10.1016/j.ejphar.2003.11.068
7. Bonano JS, Glennon RA, De Felice LJ et al (2013) Abuse-related and abuse-limiting effects of methcathinone and the synthetic "bath salts" cathinone analogs methylenedioxypyrovalerone (MDPV), methylone and mephedrone on intracranial self-stimulation in rats. Psychopharmacology (Berl). doi: 10.1007/s00213-013-3223-5
8. Bowen SE, Balster RL (1998) A direct comparison of inhalant effects on locomotor activity and schedule-controlled behavior in mice. Exp Clin Psychopharmacol 6:235-247. doi: 10.1037/1064-1297.6.3.235
9. Bowen SE, Hannigan JH (2006) Developmental toxicity of prenatal exposure to toluene. AAPS J 8:E419-E424. doi: 10.1007/BF02854915
10. Bowen SE, McDonald P (2009) Abuse pattern of toluene exposure alters mouse behavior in a waiting-for-reward operant task. Neurotoxicol Teratol 31:18-25. doi: 10.1016/j.ntt.2008.09.002
11. Bowen SE, Wiley JL, Balster RL (1996) The effects of abused inhalants on mouse behavior in an elevated plus-maze. Eur J Pharmacol 312:131-136. doi: 10.1016/0014-2999(96)00459-1
12. Bowen SE, Kimar S, Irtenkauf S (2010) Comparison of toluene-induced locomotor activity in four mouse strains. Pharmacol Biochem Behav 95:249-257. doi: 10.1016/j.pbb.2010.01.014
13. Brouette T, Anton R (2001) Clinical review of inhalants. Am J Addict 10:79-94. doi: 10.1080/105504901750160529
14. Carlezon WA, Chartoff EH (2007) Intracranial self-stimulation (ICSS) in rodents to study the neurobiology of motivation. Nat Protoc 2:2987-2995. doi: 10.1038/nprot.2007.441
15. Chan M-H, Chung S-S, Stoker AK et al (2012) Sarcosine attenuates toluene-induced motor incoordination, memory impairment, and hypothermia but not brain stimulation reward enhancement in mice. Toxicol Appl Pharmacol 265:158-165. doi: 10.1016/j.taap.2012.10.004
16. Cho AM, Coalson DW, Klock PA et al (1997) The effects of alcohol history on the reinforcing, subjective and psychomotor effects of nitrous oxide in healthy volunteers. Drug Alcohol Depend 45:63-70
17. Collado V, Nicolas E, Faulks D, Hennequin M (2007) A review of the safety of 50 % nitrous oxide/oxygen in conscious sedation. Expert Opin Drug Saf 6:559-571. doi: 10.1517/14740338.6.5.559
18. Cruz SL, Domínguez M (2011) Misusing volatile substances for their hallucinatory effects: a qualitative pilot study with Mexican teenagers and a pharmacological discussion of their hallucinations. Subst Use Misuse 46(Suppl 1):84-94. doi: 10.3109/10826084.2011.580222
19. Cruz SL, Mirshahi T, Thomas B et al (1998) Effects of the abused solvent toluene on recombinant N-methyl-d-aspartate and non-N-methyl-d-aspartate receptors expressed in Xenopus oocytes. J Pharmacol Exp Ther 286:334-340
20. Depoortere, Perrault G, Sanger DJ (1999) Intracranial self-stimulation under a progressive-ratio schedule in rats: effects of strength of stimulation, d-amphetamine, 7-OH-DPAT and haloperidol. Psychopharmacology (Berl) 142:221-229. doi: 10.1007/s002130050883
21. Dews PB (1977) Rate-dependency hypothesis. Science 198:1182-1183. doi: 10.1126/science.563103
22. Elkoussi A, Bakheet S (2011) Volatile substance misuse among street children in Upper Egypt. Subst Use Misuse 46(Suppl 1):35-39. doi: 10.3109/10826084.2011.580202
23. Emmanouil DE, Johnson CH, Quock RM (1994) Nitrous oxide anxiolytic effect in mice in the elevated plus maze: mediation by benzodiazepine receptors. Psychopharmacology (Berl) 115:167-172. doi: 10.1007/BF02244768
24. Fish EW, Riday TT, McGuigan MM et al (2010) Alcohol, cocaine, and brain stimulation-reward in C57Bl6/J and DBA2/J mice. Alcohol Clin Exp Res 34:81-89. doi: 10.1111/j.1530-0277.2009.01069.x
25. Garland EL, Howard MO, Perron BE (2009) Nitrous oxide inhalation among adolescents: prevalence, correlates, and co-occurrence with volatile solvent inhalation. J Psychoactive Drugs 41:337-347
26. Gupta SR, Palmer CA, Curé JK et al (2011) Toluene optic neurotoxicity: magnetic resonance imaging and pathologic features. Hum Pathol 42:295-298. doi: 10.1016/j.humpath.2010.08.005
27. Hannigan JH, Bowen SE (2010) Reproductive toxicology and teratology of abused toluene. Syst Biol Reprod Med 56:184-200. doi: 10.3109/19396360903377195
28. Hapfelmeier G, Zieglgänsberger W, Haseneder R et al (2000) Nitrous oxide and xenon increase the efficacy of GABA at recombinant mammalian GABA(A) receptors. Anesth Analg 91:1542-1549. doi: 10.1097/00000539-200012000-00045
29. Hoet P, Lison D (2008) Ototoxicity of toluene and styrene: state of current knowledge. Crit Rev Toxicol 38:127-170. doi: 10.1080/10408440701845443
30. Kornetsky C, Esposito RU, McLean S, Jacobson JO (1979) Intracranial self-stimulation thresholds: a model for the hedonic effects of drugs of abuse. Arch Gen Psychiatry 36:289-292
31. Lee DE, Gerasimov MR, Schiffer WK, Gifford AN (2006) Concentration- dependent conditioned place preference to inhaled toluene vapors in rats. Drug Alcohol Depend 85:87-90. doi: 10.1016/j.drugalcdep.2006.03.013
32. Lin R-J, Chen H-F, Chang Y-C, Su J-J (2011) Subacute combined degeneration caused by nitrous oxide intoxication: case reports. Acta Neurol Taiwan 20:129-137
33. Lo P-S, Chen H-H (2005) Immunohistochemical localization of toluene-induced c-Fos protein expression in the rat brain. Toxicol Lett 157:151-160, 16/j.toxlet.2005.01.014
34. Miyagawa M, Honma T, Sato M, Hasegawa H (1984) Conditioned taste aversion induced by toluene administration in rats. Neurobehav Toxicol Teratol 6:33-37
35. Moser VC, Balster RL (1985) Effects of toluene, halothane and ethanol vapor on fixed-ratio performance in mice. Pharmacol Biochem Behav 22:797-802. doi: 10.1016/0091-3057(85)90530-1
36. Moser VC, Balster RL (1986) The effects of inhaled toluene, halothane, 1,1,1-trichloroethane, and ethanol on fixed-interval responding in mice. Neurobehav Toxicol Teratol 8:525-531
37. National Research Council (2011) Guide for the care and use of laboratory animals, 8th edn. National Academies Press, Washington, DC
38. Paxinos G, Franklin KBJ (2001) The Mouse Brain in Stereotaxic Coordinates, 2nd edn. Academic Press, San Diego
39. Perit KE, Gmaz JM, Caleb Browne JD et al (2012) Distribution of c-Fos immunoreactivity in the rat brain following abuse-like toluene vapor inhalation. Neurotoxicol Teratol 34:37-46. doi: 10.1016/j.ntt.2011.10.007
40. Ramsay DS, Watson CH, Leroux BG et al (2003) Conditioned place aversion and self-administration of nitrous oxide in rats. Pharmacol Biochem Behav 74:623-633. doi: 10.1016/S0091-3057(02)01048-1
41. Reynolds LM, Engin E, Tantillo G et al (2012) Differential roles of GABA(A) receptor subtypes in benzodiazepine-induced enhancement of brain-stimulation reward. Neuropsychopharmacology 37:2531-2540. doi: 10.1038/npp.2012.115
42. Sharma S, Hryhorczuk C, Fulton S (2012) Progressive-ratio responding for palatable high-fat and high-sugar food in mice. J Vis Exp e3754. doi: 10.3791/3754
43. Shelton KL (2009) Discriminative stimulus effects of inhaled 1,1,1-trichloroethane in mice: comparison to other hydrocarbon vapors and volatile anesthetics. Psychopharmacology (Berl) 203:431-440. doi: 10.1007/s00213-008-1380-8
44. Shelton KL, Nicholson KL (2010) GABA(A) positive modulator and NMDA antagonist-like discriminative stimulus effects of isoflurane vapor in mice. Psychopharmacology (Berl) 212:559-569. doi: 10.1007/s00213-010-1979-4
45. Shelton KL, Nicholson KL (2012) GABAA-positive modulator selective discriminative stimulus effects of 1,1,1-trichloroethane vapor. Drug Alcohol Depend 121:103-109. doi: 10.1016/j.drugalcdep.2011.08.016
46. Straub CJ, Carlezon WA Jr, Rudolph U (2010) Diazepam and cocaine potentiate brain stimulation reward in C57BL/6J mice. Behav Brain Res 206:17-20. doi: 10.1016/j.bbr.2009.08.025
47. Tatum WO, Bui DD, Grant EG, Murtagh R (2010) Pseudo-Guillain-Barre syndrome due to "whippet"-induced myeloneuropathy. J Neuroimaging 20:400-401. doi: 10.1111/j.1552-6569.2009.00388.x
48. Tomasiewicz HC, Todtenkopf MS, Chartoff EH et al (2008) The kappa-opioid agonist U69,593 blocks cocaine-induced enhancement of brain stimulation reward. Biol Psychiatry 64:982-988. doi: 10.1016/j.biopsych.2008.05.029
49. Walker DJ, Zacny JP (2001) Within- and between-subject variability in the reinforcing and subjective effects of nitrous oxide in healthy volunteers. Drug Alcohol Depend 64:85-96. doi: 10.1016/S0376-8716(00)00234-9
50. Walker DJ, Zacny JP (2003) Bitonic dose-response functions for reinforcing and self-reported effects of nitrous oxide in humans. Pharmacol Biochem Behav 74:851-857
51. Wise RA (1980) Action of drugs of abuse on brain reward systems. Pharmacol Biochem Behav 13(Suppl 1):213-223
52. Wise RA, Bauco P, Carlezon WA Jr, Trojniar W (1992) Self-stimulation and drug reward mechanisms. Ann N Y Acad Sci 654:192-198. doi: 10.1111/j.1749-6632. 1992.tb25967.x
53. Wood RW, Grubman J, Weiss B (1977) Nitrous oxide self-administration by the squirrel monkey. J Pharmacol Exp Ther 202:491-499
54. Yavich L, Zvartau E (1994) A comparison of the effects of individual organic solvents and their mixture on brain stimulation reward. Pharmacol Biochem Behav 48:661-664. doi: 10.1016/0091-3057(94)90328-X
55. Yücel M, Takagi M, Walterfang M, Lubman DI (2008) Toluene misuse and long-term harms: a systematic review of the neuropsychological and neuroimaging literature. Neurosci Biobehav Rev 32:910-926. doi: 10.1016/j.neubiorev.2008.01. 006
56. Zacny JP, Walker DJ, Derus LM (2008) Choice of nitrous oxide and its subjective effects in light and moderate drinkers. Drug Alcohol Depend 98:163-168. doi: 10.1016/j.drugalcdep.2008.06.001